Can we separately report codes 96360 and 96361 for CAR-T?
For CAR-T cell administration, can we report lymphodepleting (LD) chemotherapy separately if it is administered prior to the day that cell therapy is administered?
Can we charge separately for supportive medicated injections/infusions given at the time of the cell therapy?
CPT® copyright 2022 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.